ArticleBriefings in bioinformatics2024
Cell-specific priors rescue differential gene expression in spatial spot-based technologies.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Spatial transcriptomics (ST), a breakthrough technology, captures the complex structure and state of tissues through the spatial profiling of gene expression. A variety of ST technologies have now emerged, most prominently spot-based platforms such as Visium. Despite the widespread use of ST and its distinct data characteristics, the vast majority of studies continue to analyze ST data using algorithms originally designed for older technologies such as single-cell (SC) and bulk RNA-seq-particularly when identifying differentially expressed genes (DEGs). However, it remains unclear whether these algorithms are still valid or appropriate for ST data. Therefore, here, we sought to characterize the performance of these methods by constructing an in silico simulator of ST data with a controllable and known DEG ground truth. Surprisingly, our findings reveal little variation in the performance of classic DEG algorithms-all of which fail to accurately recapture known DEGs to significant levels. We further demonstrate that cellular heterogeneity within spots is a primary cause of this poor performance and propose a simple gene-selection scheme, based on prior knowledge of cell-type specificity, to overcome this. Notably, our approach outperforms existing data-driven methods designed specifically for ST data and offers improved DEG recovery and reliability rates. In summary, our work details a conceptual framework that can be used upstream, agnostically, of any DEG algorithm to improve the accuracy of ST analysis and any downstream findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.